Turnstone Biologics 's ROA from the second quarter of 2025 to the second quarter of 2024 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Turnstone Biologics 's ROA in the second quarter of 2025?
Turnstone Biologics Corp recorded a cumulative net loss of $-47 million during 12 months ending in the second quarter of 2025, resulting in a negative return on assets (ROA) of -129.24%.

However, within the Healthcare sector 829 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2025 quarter, so far to 4543, from total ROA ranking in the first quarter of 2025 at 4610.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter
Y / Y Total Assets Change	-72.22 %	-70.61 %	-63.81 %	-55.61 %	6.39 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-47	-63	-71	-74	-75
Return On Assets (TTM)	-129.24 %	-125.44 %	-106.01 %	-88.05 %	-72.93 %
TSBX's Total Ranking	# 4543	# 4610	# 5244	# 4550	# 4504
Total Assets (TTM) in million	21	28	40	57	76
Seq. Total Assets Change	-23.55 %	-31.21 %	-29.85 %	-24.68 %	-19.15 %
Seq. Net Income Change	-	-	-	-	-

TSBX's 5 Years Annual ROA >> Back to TSBX Management Effectiveness >> Compare TSBX ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 134
Sector	# 830
Overall	# 4482

Return On Assets Statistics
High	Average	Low
-50.88 %	-91.34 %	-128.13 %
(Dec 31 2023)		(Jun 30 2025)

Financial Statements
Turnstone Biologics 's Assets	$ 21 million	TSBX's Balance sheet
Turnstone Biologics 's Income	$ -5 million	Quarterly TSBX's Income Statement
TSBX's Income by Division		See TSBX's Income by Division

Annual Return On Assets	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	FY	FY	FY
Y / Y Total Assets Change	-63.81 %	-	-	-	-
Total Assets in million	40	111	0	0	0
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-71	-55	0	0	0
Annual Return On Assets	-176.48 %	-49.77 %	-	-	-

TSBX's 5 Years Annual ROA >> Back to TSBX Management Effectiveness >> Compare TSBX ROA to its Competitors

More Return On Assets Ratios
TSBX's' Return on Assets at Yahoo Finance
Biotechnology & Pharmaceuticals Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
TSBX's Roa Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for TSBX's Competitors
Subscribers only: Roa for Turnstone Biologics 's Suppliers
Subscribers only: Return On Assets for TSBX's Customers

You may also want to know
TSBX's Roi	TSBX's Inventory Turnover Ratio	TSBX's Growth Rates	TSBX's Dividend Comparisons
	TSBX's Profitability Ratios	TSBX's Asset Turnover Ratio	TSBX's Dividend Growth
TSBX's Roe	TSBX's Valuation Ratios	TSBX's Financial Strength Ratios	TSBX's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2025, within Healthcare Sector

ROA

Date modified: 2026-08-29T17:48:16+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.